WallStreetZenWallStreetZen

NYSEMKT: AEON
Aeon Biopharma Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AEON earnings and revenue history

Current Revenue
$0.0
Current Earnings
$24.0M
Current Profit Margin
0%

AEON Return on Equity

Current Company
-10.9%
Current Industry
-63.5%
Current Market
188%
AEON's Return on Equity (-16.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AEON announces earnings.

AEON Return on Assets

Current Company
272.9%
Current Industry
2.9%
AEON is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AEON Return on Capital Employed

Current Company
-387.59%
Current Industry
19.5%
AEON's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AEON vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AEON$0.00$24.09M$24.05MN/AN/A
COYA$6.00M-$7.24M-$7.99MN/AN/A
DBVT$15.73M-$86.72M-$72.73M-0.69%N/A
KPTI$146.03M-$118.42M-$143.10M+36.93%N/A
VXRT$7.38M-$73.58M-$82.47M+12.15%N/A
View Top Biotech Stocks

Aeon Biopharma Earnings & Revenue FAQ

What were AEON's earnings last quarter?

Aeon Biopharma (NYSEMKT: AEON) reported Q4 2023 earnings per share (EPS) of -$0.70, up 180% year over year. Total Aeon Biopharma earnings for the quarter were -$26.24 million. In the same quarter last year, Aeon Biopharma's earnings per share (EPS) was -$0.25.

If you're new to stock investing, here's how to buy Aeon Biopharma stock.

What was AEON's earnings growth in the past year?

As of Q2 2024, Aeon Biopharma's earnings has grown year over year. Aeon Biopharma's earnings in the past year totalled $24.05 million.

What was AEON's revenue last quarter?

Aeon Biopharma (NYSEMKT: AEON) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Aeon Biopharma's revenue was $0.00.

What was AEON's revenue growth in the past year?

As of Q2 2024, Aeon Biopharma's revenue has grown null year over year. Aeon Biopharma's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.